Nicolas Dumaz

9PUBLICATIONS
8CO-AUTHORS
Molecular targetsGene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 07, 2026
RAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma.

|Apr 03, 2024
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.

Coralie Reger De Moura, Baptiste Louveau, Fanélie Jouenne

|Jun 10, 2023
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro.

Julie Delyon, Anaïs Vallet, Mélanie Bernard-Cacciarella

|Feb 26, 2022
Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.

Alexandra Landras, Coralie Reger de Moura, Bruno O Villoutreix

|Oct 23, 2021
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy.

Ahlem Jebali, Maxime Battistella, Céleste Lebbé

|Apr 30, 2020
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma.

Pauline Tétu, Julie Delyon, Jocelyne André

Pageof 2

Frequent Collaborators

3 joint publications

Coralie Reger de Moura

3 joint publications

Samia Mourah

2 joint publications

Baptiste Louveau

2 joint publications

Julie Delyon